CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geradts, J.
Right arrow Articles by Minna, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geradts, J.
Right arrow Articles by Minna, J. D.

Cell Growth & Differentiation, Vol 4, Issue 10 799-809, Copyright © 1993 by American Association of Cancer Research

ARTICLES

Human lung cancer cell lines exhibit resistance to retinoic acid treatment

J Geradts, JY Chen, EK Russell, JR Yankaskas, L Nieves and JD Minna
National Cancer Institute-Navy Medical Oncology Branch, National Naval Medical Center, Bethesda, Maryland 20889.

Retinoic acid (RA) and nuclear retinoic acid receptors (RARs) have been implicated in a variety of human malignancies including lung cancer, and RA has been proposed as a chemopreventive agent for bronchogenic carcinoma. Normal human tracheobronchial epithelial cells show dramatic induction of RAR-beta mRNA and significant growth inhibition after RA treatment. In contrast, 17 of 22 small cell lung cancer (SCLC) and 9 of 15 non-SCLC lines treated with 1 microM RA showed no significant growth inhibition. Of interest, 5 SCLC lines with high levels of myc gene family expression related to c-, N-, or L-myc gene amplification exhibited growth inhibition (28-87%), whereas 2 non-SCLC lines actually showed growth stimulation after treatment with 1 microM RA. The lines varied greatly in their constitutive expression of RAR-beta mRNA, and 15 of 20 SCLC and 8 of 15 non-SCLC lines failed to show RAR-beta mRNA induction after RA treatment. Six cell lines showed possible alterations in the coding region of RAR-beta by complementary DNA (cDNA)/polymerase chain reaction (PCR) analysis using primers common to the RAR-beta1,2,3 isoforms, since other regions would undergo cDNA/PCR amplification whereas the DNA binding domain would not. Nonetheless, no abnormal band shift patterns in cDNA amplified by PCR were found by single strand conformation polymorphism analysis covering all 1344 base pairs of the RAR-beta open reading frame. Finally, no abnormalities in RAR-alpha gene structure or expression were identified by Southern and Northern blot analysis, including lines with cytogenetic abnormalities of 17q21. We conclude that abnormalities of the RAR-beta system are common in human lung cancer cell lines.


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
F. Lian, D. E. Smith, H. Ernst, R. M. Russell, and X.-D. Wang
Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo
Carcinogenesis, July 1, 2007; 28(7): 1567 - 1574.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. D. Liang, S. M. Lippman, T.-T. Wu, R. Lotan, and X.-C. Xu
RRIG1 Mediates Effects of Retinoic Acid Receptor {beta}2 on Tumor Cell Growth and Gene Expression through Binding to and Inhibition of RhoA.
Cancer Res., July 15, 2006; 66(14): 7111 - 7118.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Y. T. Kim, S. H. Lee, S. W. Sung, and J. H. Kim
Can Aberrant Promoter Hypermethylation of CpG Islands Predict the Clinical Outcome of Non-Small Cell Lung Cancer After Curative Resection?
Ann. Thorac. Surg., April 1, 2005; 79(4): 1180 - 1188.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
H. Srinivas, D. M. Juroske, S. Kalyankrishna, D. D. Cody, R. E. Price, X.-C. Xu, R. Narayanan, N. L. Weigel, and J. M. Kurie
c-Jun N-Terminal Kinase Contributes to Aberrant Retinoid Signaling in Lung Cancer Cells by Phosphorylating and Inducing Proteasomal Degradation of Retinoic Acid Receptor {alpha}
Mol. Cell. Biol., February 1, 2005; 25(3): 1054 - 1069.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. S. Kim, H. Lee, H. Kim, Y. M. Shim, J. Han, J. Park, and D.-H. Kim
Promoter Methylation of Retinoic Acid Receptor Beta 2 and the Development of Second Primary Lung Cancers in Non-Small-Cell Lung Cancer
J. Clin. Oncol., September 1, 2004; 22(17): 3443 - 3450.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. M. Youssef, D. Lotan, J.-P. Issa, K. Wakasa, Y.-H. Fan, L. Mao, K. Hassan, L. Feng, J. J. Lee, S. M. Lippman, et al.
Hypermethylation of the Retinoic Acid Receptor-{beta}2 Gene in Head and Neck Carcinogenesis
Clin. Cancer Res., March 1, 2004; 10(5): 1733 - 1742.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
S. Zochbauer-Muller, J. D. Minna, and A. F. Gazdar
Aberrant DNA Methylation in Lung Cancer: Biological and Clinical Implications
Oncologist, October 1, 2002; 7(5): 451 - 457.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y.-A. Suh, H.-Y. Lee, A. Virmani, J. Wong, K. K. Mann, W. H. Miller Jr., A. Gazdar, and J. M. Kurie
Loss of Retinoic Acid Receptor {beta} Gene Expression Is Linked to Aberrant Histone H3 Acetylation in Lung Cancer Cell Lines
Cancer Res., July 15, 2002; 62(14): 3945 - 3949.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. M. Lippman, J. J. Lee, D. D. Karp, E. E. Vokes, S. E. Benner, G. E. Goodman, F. R. Khuri, R. Marks, R. J. Winn, W. Fry, et al.
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
J Natl Cancer Inst, April 18, 2001; 93(8): 605 - 618.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Guo, D. M Nanus, A. Ruiz, R. R Rando, D. Bok, and L. J Gudas
Reduced Levels of Retinyl Esters and Vitamin A in Human Renal Cancers
Cancer Res., March 1, 2001; 61(6): 2774 - 2781.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
A. F. Gazdar, S. Zochbauer-Moller, A. Virmani, J. Kurie, J. D. Minna, and S. Lam
RESPONSE: Re: Promoter Methylation and Silencing of the Retinoic Acid Receptor-{{beta}} Gene in Lung Carcinomas
J Natl Cancer Inst, January 3, 2001; 93(1): 67 - 68.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Zöchbauer-Müller, K. M. Fong, A. K. Virmani, J. Geradts, A. F. Gazdar, and J. D. Minna
Aberrant Promoter Methylation of Multiple Genes in Non-Small Cell Lung Cancers
Cancer Res., January 1, 2001; 61(1): 249 - 255.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
H. Wan, W. K. Hong, and R. Lotan
Increased Retinoic Acid Responsiveness in Lung Carcinoma Cells that Are Nonresponsive Despite the Presence of Endogenous Retinoic Acid Receptor (RAR) {beta} by Expression of Exogenous Retinoid Receptors Retinoid X Receptor {{alpha}}, RAR{{alpha}}, and RAR{{gamma}}
Cancer Res., January 1, 2001; 61(2): 556 - 564.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
S. Y. Kim, H. Adachi, J. S. Koo, and A. M. Jetten
Induction of the Cytochrome P450 Gene CYP26 during Mucous Cell Differentiation of Normal Human Tracheobronchial Epithelial Cells
Mol. Pharmacol., September 1, 2000; 58(3): 483 - 490.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
A. K. Virmani, A. Rathi, S. Zochbauer-Muller, N. Sacchi, Y. Fukuyama, D. Bryant, A. Maitra, S. Heda, K. M. Fong, F. Thunnissen, et al.
Promoter Methylation and Silencing of the Retinoic Acid Receptor-{beta} Gene in Lung Carcinomas
J Natl Cancer Inst, August 16, 2000; 92(16): 1303 - 1307.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. R. Khuri, R. Lotan, B. L. Kemp, S. M. Lippman, H. Wu, L. Feng, J. J. Lee, C. S. Cooksley, B. Parr, E. Chang, et al.
Retinoic Acid Receptor-Beta as a Prognostic Indicator in Stage I Non-Small-Cell Lung Cancer
J. Clin. Oncol., August 15, 2000; 18(15): 2798 - 2804.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. Kurie, J. S. Lee, F. R. Khuri, L. Mao, R. C. Morice, J. J. Lee, G. L. Walsh, A. Broxson, S. M. Lippman, J. Y. Ro, et al.
N-(4-Hydroxyphenyl)Retinamide in the Chemoprevention of Squamous Metaplasia and Dysplasia of the Bronchial Epithelium
Clin. Cancer Res., August 1, 2000; 6(8): 2973 - 2979.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
X.-C. Xu, J. S. Lee, J. J. Lee, R. C. Morice, X. Liu, S. M. Lippman, W. K. Hong, and R. Lotan
Nuclear Retinoid Acid Receptor Beta in Bronchial Epithelium of Smokers Before and During Chemoprevention
J Natl Cancer Inst, August 4, 1999; 91(15): 1317 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Sueoka, H.-Y. Lee, G. L. Walsh, W. K. Hong, and J. M. Kurie
Posttranslational Mechanisms Contribute to the Suppression of Specific Cyclin: CDK Complexes by All-Trans Retinoic Acid in Human Bronchial Epithelial Cells
Cancer Res., August 1, 1999; 59(15): 3838 - 3844.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. J. Berg, D. M. Nanus, A. Leung, K. T. Brown, B. Hutchinson, M. Mazumdar, X.-C. Xu, R. Lotan, V. E. Reuter, and R. J. Motzer
Up-Regulation of Retinoic Acid Receptor {beta} Expression in Renal Cancers in Vivo Correlates with Response to 13-cis-Retinoic Acid and Interferon-{{alpha}}-2a
Clin. Cancer Res., July 1, 1999; 5(7): 1671 - 1675.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
R. Lotan
Aberrant Expression of Retinoid Receptors and Lung Carcinogenesis
J Natl Cancer Inst, June 16, 1999; 91(12): 989 - 991.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
X.-C. Xu, X. Liu, E. Tahara, S. M. Lippman, and R. Lotan
Expression and Up-Regulation of Retinoic Acid Receptor-{beta} Is Associated with Retinoid Sensitivity and Colony Formation in Esophageal Cancer Cell Lines
Cancer Res., May 1, 1999; 59(10): 2477 - 2483.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Sakaue, H. Adachi, and A. M. Jetten
Post-Transcriptional Regulation of MyD118 and GADD45 in Human Lung Carcinoma Cells During 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid-Induced Apoptosis
Mol. Pharmacol., April 1, 1999; 55(4): 668 - 676.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
S.-Y. Sun, J. M. Kurie, P. Yue, M. I. Dawson, B. Shroot, R. A. S. Chandraratna, W. K. Hong, and R. Lotan
Differential Responses of Normal, Premalignant, and Malignant Human Bronchial Epithelial Cells to Receptor-selective Retinoids
Clin. Cancer Res., February 1, 1999; 5(2): 431 - 437.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. J. Campbell, S. Park, M. R. Uskokovic, M. I. Dawson, and H. P. Koeffler
Expression of Retinoic Acid Receptor-{beta} Sensitizes Prostate Cancer Cells to Growth Inhibition Mediated by Combinations of Retinoids and a 19-nor Hexafluoride Vitamin D3 Analog
Endocrinology, April 1, 1998; 139(4): 1972 - 1980.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
H. Adachi, G. Preston, B. Harvat, M. I. Dawson, and A. M. Jetten
Inhibition of Cell Proliferation and Induction of Apoptosis by the Retinoid AHPN in Human Lung Carcinoma Cells
Am. J. Respir. Cell Mol. Biol., March 1, 1998; 18(3): 323 - 333.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
B.-j. M. van der Leede, C. E. van den Brink, W. W. M. Pijnappel, E. Sonneveld, P. T. van der Saag, and B. van der Burg
Autoinduction of Retinoic Acid Metabolism to Polar Derivatives with Decreased Biological Activity in Retinoic Acid-sensitive, but Not in Retinoic Acid-resistant Human Breast Cancer Cells
J. Biol. Chem., July 18, 1997; 272(29): 17921 - 17928.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. Lotan, X.-C. Xu, S. M. Lippman, J. Y. Ro, J. S. Lee, J. J. Lee, and W. K. Hong
Suppression of Retinoic Acid Receptor-{beta} in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin
N. Engl. J. Med., May 25, 1995; 332(21): 1405 - 1411.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S.-Y. Sun, H. Wan, P. Yue, W. K. Hong, and R. Lotan
Evidence That Retinoic Acid Receptor beta Induction by Retinoids Is Important for Tumor Cell Growth Inhibition
J. Biol. Chem., May 26, 2000; 275(22): 17149 - 17153.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1993 by the American Association of Cancer Research.